Osteonectin overexpression in the case of prostate cancer with intraluminal inclusions

Piddubnyi, Artem Mykhailovych; Moskalenko, Roman Andriiovych; Radomychelski, I.-M.; Lyndin, Mykola Serhiiovych; Sikora, Vladyslav Volodymyrovych; Romaniuk, Anatolii Mykolaiovych

Please use this identifier to cite or link to this item: http://essuir.sumdu.edu.ua/handle/123456789/75024

Or use following links to share this resource in social networks: Recommend this item

Title	Osteonectin overexpression in the case of prostate cancer with intraluminal inclusions
Authors	Piddubnyi, Artem Mykhailovych Moskalenko, Roman Andriiovych Radomychelski, I.-M. Lyndin, Mykola Serhiiovych Sikora, Vladyslav Volodymyrovych Romaniuk, Anatolii Mykolaiovych
ORCID	http://orcid.org/0000-0002-6508-0131 http://orcid.org/0000-0002-2342-0337 http://orcid.org/0000-0003-4385-3903 http://orcid.org/0000-0002-4147-6879 http://orcid.org/0000-0003-2560-1382
Keywords	остеонектін остеонектин оsteonectin
Type	Conference Papers
Date of Issue	2018
URI	http://essuir.sumdu.edu.ua/handle/123456789/75024
Publisher	Springer
License
Citation	Piddubnyi, A. Osteonectin overexpression in the case of prostate cancer with intraluminal inclusions [Текст] / A. Piddubnyi, R. Moskalenko, I.-M. Radomychelski et al. // Virchows Archiv. European Journal of Pathology. – 2018. – Vol. 473, Suppl 1. – S.45. – Pathology: Path to Precision medicine : 30th European Congress of Pathology, 8–12 September 2018, Bilbao, Spain.
Abstract	Background & Objective: Osteonectin (OSN) is secreted by osteoblasts during bone formation, initiating mineralization and promoting mineral crystal formation at sites of ectopic calcification. Also OSN was found in many types of human malignant tumours. The aim is to study the OSN expression in patients with prostate cancer (PC) and the presence of intraluminal inclusions (prostatolithes and amyloid cells).
Appears in Collections:	Наукові видання (НН МІ)